BD Micro-Fine Ultra™ 4mm x 0,23mm (32G) pen needle

BD Micro-Fine Ultra™ 4mm x 0,23mm (32G) pen needle

With Pentapoint™ the technology for more comfort

Clinically demonstrated to reduce the pain of injection1


BD Micro-Fine Ultra™ 4mm x 0,23mm pen needle for better diabetes managment

  • Contributes to reducing the risks of injecting into the muscle and therefore may help to reduce the risk of hypoglycaemia2.
  • Simple injection technique, without lifted skin fold in most patients4.

1 Hirsch L, et al. The impact of a modified needle tip geometry on penetration force as well as acceptability, preference and perceived pain in subjects with diabetes. J Diab Sci Tech 2012.
2 Frid Anders, Ostman Jan & Linde Brigitta. Hypoglycaemia Risk During Exercise After Intramuscular Injection of Insulin in Thigh in IDDM. Diabetes Care, Vol. 13, No. 5, May 1990, 473-477.
3 Gibney MA, Arce CH, Byron KJ, Hirsch LJ. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations. Curr Med Res Opin 2010;26:1519-30.
4 Frid al, New Injection Recommendations for Patients with Diabetes, Diabetes & Metabolism, September 2010, Vol.36, Special issue 2.


The BD Diabetes Learning Center describes the causes of diabetes, its symptoms, and diabetes complications such as retinopathy and neuropathy. This site contains detailed information about blood glucose monitoring, insulin injection and safe sharps disposal. Interactive quizzes, educational literature downloads and animated demonstrations help to teach diabetes care skills.

Important Note: The content of this website is not intended to be a substitute for professional medical advice, diagnosis or treatment. Do not disregard your doctor's advice or delay in seeking it because of something you have read in this website.

Unless otherwise noted, BD, BD logo and all other trademarks are property of Becton Dickinson and Company. © 2017 BD